Novavax
€7.37
1074
-€0.39-5.01% Today
Statistics
Day High
7.37
Day Low
7.16
52W High
8.76
52W Low
4.71
Volume
4,419
Avg. Volume
1,888
Mkt Cap
1.2B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Dec 7
€0.08
Nov 7
€0.08
Oct 7
€0.08
Sep 7
€0.08
Aug 7
€0.08
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
4MarExpected
Expected EPS
-0.41237044757999997
Actual EPS
N/A
Financials
-27.3%Profit Margin
Unprofitable1.29BRevenue
-353.5MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NVAX.VI. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Pfizer
PFE
Mkt Cap140.15B
BioNTech
BNTX
Mkt Cap24.99B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Astrazeneca
AZN
Mkt Cap256.58B
Sanofi
SNY
Mkt Cap124.45B
GSK
GSK
Mkt Cap94.51B
CureVac N.V.
CVAC
Mkt Cap1.2B
Novavax
NVAX
Mkt Cap1.36B
Dynavax Technologies
DVAX
Mkt Cap1.2B
About
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Show more...
CEO
Mr. John Charles Jacobs M.B.A.
Employees
952
Country
US
ISIN
US6700024010
Listings
0 Comments
Share your thoughts
FAQ
What is Novavax stock price today?▼
The current price of NVAX.VI is €7.37 EUR — it has decreased by -5.01% in the past 24 hours. Watch Novavax stock price performance more closely on the chart.
What is Novavax stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novavax stocks are traded under the ticker NVAX.VI.
Is Novavax stock price growing?▼
NVAX.VI stock has fallen by -9.05% compared to the previous week, the month change is a +21.56% rise, over the last year Novavax has showed a -15.67% decrease.
What is Novavax market cap?▼
Today Novavax has the market capitalization of 1.2B
When is the next Novavax earnings date?▼
Novavax is going to release the next earnings report on March 04, 2026.
What were Novavax earnings last quarter?▼
NVAX.VI earnings for the last quarter are -1.08 EUR per share, whereas the estimation was -1.04 EUR resulting in a -4.49% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Novavax revenue for the last year?▼
Novavax revenue for the last year amounts to 1.29B EUR.
What is Novavax net income for the last year?▼
NVAX.VI net income for the last year is -353.5M EUR.
Does Novavax pay dividends?▼
Yes, NVAX.VI dividends are paid monthly. The last dividend per share was 0.08 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Novavax have?▼
As of February 02, 2026, the company has 952 employees.
In which sector is Novavax located?▼
Novavax operates in the Industrials sector.
When did Novavax complete a stock split?▼
Novavax has not had any recent stock splits.
Where is Novavax headquartered?▼
Novavax is headquartered in Gaithersburg, US.